Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

12.16
Delayed Data
As of Feb 27
 +0.23 / +1.93%
Today’s Change
10.85
Today|||52-Week Range
18.48
-14.06%
Year-to-Date

Today’s Trading

Previous close11.93
Today’s open11.83
Day’s range11.51 - 12.36
Volume2,912,620
Average volume (3 months)1,606,872
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-63.84%
Earnings growth (this year)-98.90%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales149.87
Price/Book22.14

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo BioSciences ...-0.15-0.88%
NXTMNxStage Medical Inc-0.93-5.14%
BRLIBio-Reference Labora...-0.30-0.85%
ARIAARIAD Pharmaceutical...-0.04-0.49%
Data as of 3:59pm ET, 02/27/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$7.0M
Annual profit (last year)-$46.7M
Net profit margin-667.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ronald Bentsur
President, Chief Operating Officer &
Executive VP
Gregory P. Madison
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account